Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024
Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024
Wednesday, October 30, 2024LAVAL, Quebec, October 9, 2024 – Bausch Health Companies Inc. (NYSE/TSX: BHC) will release third quarter 2024 financial results after market close on Wednesday, October 30, 2024. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
2024年10月9日，博士健康公司（紐約證券交易所/多倫多證券交易所：BHC）將於2024年10月30日（週三）市場收盤後公佈第三季度2024年財務業績。博士健康將於美國東部時間下午5:00舉行電話會議和現場網絡廣播，討論業績並提供業務更新。會議前所有材料將在博士健康網站的投資者關係部分提前提供。
Conference Call Details
電話會議詳情
Date: |
Wednesday, October 30, 2024 |
Time: |
5:00 p.m. U.S. EST |
Webcast: |
日期： |
2024年10月30日，星期三 |
時間： |
美國東部時間下午5:00 |
網絡直播： |
A replay of the conference call will be available on the investor relations website.
電話會議的錄音重播將在投資者關係網站上提供。
To participate in the live Q&A session, please register using this link to receive an email confirming your registration with further details.
要參加現場問答環節，請使用此鏈接註冊，以便收到確認註冊的電子郵件及進一步詳細信息。
About Bausch Health
關於Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit and connect with us on LinkedIn.
bausch health公司（紐交所/tsx: BHC）是一家全球多元化的藥品公司，通過我們不懈的努力致力於提供更好的醫療保健成果，豐富人們的生活。我們主要在胃腸病學、肝病學、神經病學、皮膚科、醫學美容器械、國際藥品和眼部健康領域開發、生產和銷售一系列產品，通過對Bausch + Lomb的控股權。我們的抱負是成爲一家全球一體化的醫療保健公司，受患者、醫療專業人士、員工和投資者信賴和重視。欲了解更多信息，請訪問 ，並在LinkedIn上與我們聯繫。
| Investor Contact: | Media Contact: |
| Garen Sarafian ir@bauschhealth.com (877) 281-6642(toll-free) |
Katie Savastano corporate.communications@bauschhealth.com (908) 541-3785 |
| 投資者聯繫人： | 媒體聯繫人： |
| 加倫·薩拉菲安 ir@bauschhealth.com （877）281-6642（免費電話） |
Katie Savastano corporate.communications@bauschhealth.com （908）541-3785 |
譯文內容由第三人軟體翻譯。
